We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
+1.46%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$6.68B
AUM Growth
+$582M
(+9.5%)
Cap. Flow
+$535M
Cap. Flow
% of AUM
8%
Top 10 Holdings %
Top 10 Hldgs %
12.65%
Holding
1,053
New
75
Increased
598
Reduced
299
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$24.3M |
| 2 |
Accenture
ACN
|
+$21.8M |
| 3 |
Honeywell
HON
|
+$21.1M |
| 4 |
JPMorgan Chase
JPM
|
+$20.4M |
| 5 |
GE Aerospace
GE
|
+$19.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Growth ETF
VUG
|
+$26.4M |
| 2 |
Factset
FDS
|
+$20.5M |
| 3 |
iShares Currency Hedged MSCI Eurozone ETF
HEZU
|
+$20.1M |
| 4 |
Vanguard Value ETF
VTV
|
+$17.3M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.16% |
| 2 | Technology | 14.03% |
| 3 | Healthcare | 12.2% |
| 4 | Industrials | 10.96% |
| 5 | Consumer Discretionary | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRI
551
DELISTED
Albany Molecular Research Inc
AMRI
| $2.53M | 0.04% |
165,466
+3,948
| +2% | +$61.9K |
|
552
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
| $2.53M | 0.04% |
50,719
-412
| -0.8% | -$19.4K |
|
553
Trip.com Group
TCOM
$27.5B
| $2.52M | 0.04% |
57,020
+17,021
| +43% | +$712K |
|
554
Sabra Healthcare REIT
SBRA
$5.64B
| $2.5M | 0.04% |
124,255
-41,338
| -25% | -$792K |
|
555
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.82B
| $2.5M | 0.04% |
96,142
+14,318
| +17% | +$362K |
|
556
Norfolk Southern
NSC
$78.8B
| $2.49M | 0.04% |
29,867
+3,289
| +12% | +$249K |
|
557
Sabesp
SBS
$19.7B
| $2.48M | 0.04% |
1,939,090
-320,178
| -14% | -$338K |
|
558
NetApp
NTAP
$32.9B
| $2.48M | 0.04% |
90,909
+20,077
| +28% | +$486K |
|
559
Grupo Cibest SA
CIB
$20.4B
| $2.47M | 0.04% |
72,383
+52,332
| +261% | +$1.56M |
|
|
VGR
560
DELISTED
Vector Group Ltd.
VGR
| $2.47M | 0.04% |
185,416
-6,796
| -4% | -$90.5K |
|
561
Lincoln Electric
LECO
$13.8B
| $2.46M | 0.04% |
42,048
+3,042
| +8% | +$166K |
|
562
Omega Healthcare
OHI
$15.4B
| $2.45M | 0.04% |
69,448
+52,398
| +307% | +$1.72M |
|
|
CBF
563
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $2.45M | 0.04% |
79,383
+4,049
| +5% | +$121K |
|
564
Truist Financial
TFC
$63.2B
| $2.44M | 0.04% |
73,404
+946
| +1% | +$31.4K |
|
565
TriMas Corp
TRS
$1.43B
| $2.44M | 0.04% |
139,060
-121
| -0.1% | -$2.07K |
|
566
CMS Energy
CMS
$23.1B
| $2.43M | 0.04% |
57,336
+3,499
| +6% | +$137K |
|
567
iShares Core S&P US Growth ETF
IUSG
$31.1B
| $2.43M | 0.04% |
60,002
-37,424
| -38% | -$1.44M |
|
568
Cameco
CCJ
$38.3B
| $2.43M | 0.04% |
189,222
+7,945
| +4% | +$95K |
|
569
Myriad Genetics
MYGN
$530M
| $2.42M | 0.04% |
64,792
+38,658
| +148% | +$1.46M |
|
570
VF Corp
VFC
$6.68B
| $2.41M | 0.04% |
39,499
+19,774
| +100% | +$1.15M |
|
571
Cigna
CI
$76.6B
| $2.41M | 0.04% |
17,545
+4,291
| +32% | +$589K |
|
572
Newmont
NEM
$98.2B
| $2.4M | 0.04% |
90,183
-286
| -0.3% | -$6.62K |
|
573
CDW
CDW
$17.1B
| $2.39M | 0.04% |
57,676
+5,494
| +11% | +$214K |
|
574
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $2.38M | 0.04% |
27,606
+4,896
| +22% | +$415K |
|
575
Micron Technology
MU
$1.04T
| $2.38M | 0.04% |
227,419
-28,444
| -11% | -$318K |
|
Similar funds
Natixis Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Natixis Advisors held 1,053 positions worth $6.68B, up 9.5% from $6.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Natixis Advisors deployed $535M of net new capital in Q1 2016, opening 75 new positions and adding to 598 existing holdings. Its largest new stake was Broadcom: 1,202,100 shares worth $18.6M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Growth ETF, an estimated $26.4M trimmed.
- Natixis Advisors's largest Q1 2016 buy was Broadcom: 1,202,100 shares worth $18.6M.
- Natixis Advisors added most to Johnson & Johnson in Q1 2016, an estimated $24.3M increase.
- Natixis Advisors's biggest Q1 2016 reduction was Vanguard Growth ETF, cutting an estimated $26.4M.
- Natixis Advisors fully exited Factset in Q1 2016, selling an estimated $20.5M.
- Natixis Advisors's ten largest holdings make up 13% of its $6.68B portfolio in Q1 2016.
- Natixis Advisors opened 75 new positions and closed 81 in Q1 2016.
- Natixis Advisors's portfolio value rose 9.5% quarter-over-quarter to $6.68B.
Based on Natixis Advisors's 13F filing for Q1 2016, filed 6 May 2016.